Abstract Myocarditis is more severe in men than in women and difficult to diagnose due to a lack of imaging modalities that directly detect myocardial inflammation. Translocator protein 18 kDa (TSPO) is used extensively to image brain inflammation due to its presence in CD11b + brain microglia. In this study, we examined expression of TSPO and CD11b in mice with coxsackievirus B3 (CVB3) myocarditis and biopsy sections from myocarditis patients in order to determine if it could be used to image myocarditis. We found that male mice with CVB3 myocarditis upregulated more genes associated with TSPO activation than female mice. TSPO expression was increased in the heart of male mice and men with myocarditis compared with female subjects due to testosterone, where it was expressed predominantly in CD11b + immune cells. We show that TSPO ligands detect myocardial inflammation using microSPECT, with increased uptake of [ 125 I]-IodoDPA-713 in male mice with CVB3 myocarditis compared with undiseased controls.
Introduction
Myocarditis, or inflammation of the myocardium, leads to a significant minority of dilated cardiomyopathy (DCM) cases in the USA [1] . However, the true incidence and prevalence of myocarditis are unknown due to the lack of biomarkers and imaging modalities that directly detect myocardial inflammation [1, 2] . Echocardiography and cardiac magnetic resonance imaging (cMRI) are currently used to diagnose myocarditis and measure changes in heart function, edema, fibrosis, and dilation, but these methods do not directly detect myocardial inflammation [3, 4] . Thus, there is a need for a noninvasive method to determine the presence and severity of myocarditis in addition to echocardiography and cMRI that does not require endomyocardial biopsy.
Translocator protein 18 kDa (TSPO), previously called peripheral benzodiazepine receptor [5] , is used extensively to image brain inflammation in patients due to its presence in CD11b + brain microglia (macrophages) [6] [7] [8] . In healthy humans and rodents, the highest density of TSPO expression is found in steroidogenic tissues like the testes and ovaries, with relatively high levels also detected in the heart, lung, and liver [9] [10] [11] . TSPO is the rate-limiting step in the transport of cholesterol into the inner mitochondrial membrane where it is used to make steroids [9, 10, 12, 13] , and TSPO is required for expression of estrogen, progesterone, and testosterone in the heart and by immune cells like macrophages [6, 9, 14, 15] . Although TSPO imaging is routinely used to assess brain inflammation in patients via positron emission tomography (PET) or single-photon emission computed tomography (SPECT) [6-8, 16, 17] and more recently to detect inflammation in atherosclerotic plaques [15, [18] [19] [20] , its potential as an imaging tool for myocardial inflammation has not been previously examined.
Similar to other cardiovascular diseases, the incidence and severity of myocarditis, DCM, and heart failure are higher in men and male mice with a better long-term outcome in female subjects [21] [22] [23] . A recent clinical study of myocarditis and acute DCM patients found that myocardial recovery and transplant-free survival were significantly worse in men compared with women, driven by a marked difference in survival [23] . While most cases of suspected myocarditis are not linked to a specific cause, viral infections such as coxsackievirus B3 (CVB3) are the most commonly identified cause of myocarditis in developed countries [1, 4] . Previously, we showed in a mouse model of CVB3 myocarditis that testosterone increases CD11b expression on cardiac macrophages during acute myocarditis in male mice [24, 25] . CD11b is also known as complement receptor 3 and is upregulated on activated macrophages/microglia. CD11b + immune cells make up around 80 % of the inflammatory infiltrate during acute CVB3 myocarditis [24] , which suggests that a marker like TSPO that could detect these cells would provide information on the severity of myocarditis. Additionally, cardiac CD11b + immune cells were associated with progression from CVB3 myocarditis to DCM and heart failure in male mice [13, 21, 24, 25] . Based on these data, we hypothesized that TSPO may be present in cardiac CD11b + immune cells during myocarditis making TSPO a good candidate for imaging myocardial inflammation.
Methods

Myocarditis Patients
Myocardial inflammation was confirmed histologically in endomyocardial heart biopsies from 20 myocarditis patients at Mayo Clinic (n=10/sex). Approval was obtained from the Institutional Review Boards at the Mayo Clinic and Johns Hopkins University for the study. Procedures are in accordance with the ethical standards of the Helsinki Declaration of 1975, as revised in 2000. Some of the samples were obtained from a clinical trial that is registered at www.clinicaltrials.gov/ (NCT0004482). All clinical samples used in this study were from patients where consent was obtained for future research.
Immunohistochemistry
Biopsy sections from myocarditis patients were deparaffinized, blocked, stained with rabbit antihuman CD11b (Clone EP1345Y, Abcam, Cambridge, MA) at 1:250 dilution for 1 h at room temperature followed by a biotinylated secondary antibody for 1 h, and incubated with 3,3′-diaminobenzidine (DAB) (dark brown). Tissue sections were counterstained with hematoxylin (blue background).
Animal Model
Male and female 6-8-week-old BALB/cJ mice (Cat. No. 000651) were obtained from the Jackson Laboratory (Bar Harbor, ME). Mice were maintained under pathogen-free conditions in the animal facility at the Johns Hopkins School of Medicine, and approval was obtained from the Animal Care and Use Committee of Johns Hopkins University and Columbia University for all procedures. Procedures are in accordance with the ethical standards of the Helsinki Declaration of 1975, as revised in 2000. Seven to ten mice/group were inoculated intraperitoneally with 10 3 plaque forming units of a heart-passaged stock of CVB3 or sterile phosphate-buffered saline (PBS) and the hearts and sera collected on day 10 post infection (pi), according to [26, 27] . All mouse studies conducted in this study were analyzed during peak myocarditis at day 10 pi.
Histology
Formalin-fixed hearts from myocarditis patients or mice were stained with hematoxylin and eosin to detect inflammation. Myocarditis in mice was assessed as the percentage of the heart section with inflammation compared with the overall size of the heart section using a microscope eyepiece grid, as previously reported [21, 24, 25] .
Gonadectomy
Prepubertal 6-week-old male BALB/c mice were bilaterally gonadectomized or received a sham operation under ketamine (50 mg/kg)/xylazine (5 mg/kg) anesthesia (Phoenix Pharmaceutical, St. Joseph, MO), as previously reported [21, 25] . For testosterone (Te) replacement, slow-release testosterone or control pellets were implanted subcutaneously, according to [28] . Mice were allowed 2 weeks to recover from the operation before myocarditis was induced. Testosterone was measured in sera using a Quantikine ELISA kit (R&D Systems, Minneapolis, MN).
Microarray
The whole hearts from male and female BALB/c mice with CVB3 myocarditis were compared with the normal hearts from PBS-inoculated control male and female mice by microarray; n=3/group based on echocardiography of representative disease between sexes [21] . RNA (100 ng) was processed for hybridization to Affymetrix Mouse Gene ST 1.0 microarrays using the Affymetrix GeneChip Whole Transcript Sense Target Labeling Assay (Affymetrix, Santa Clara, CA), as previously reported [13, 21] . The microarray was performed by the Johns Hopkins Bloomberg School of Public Health Genomic Analysis and Sequencing Core Facility. Analysis of microarray data was performed with Partek Genomics Suite (GS) Version 6.4 (Partek, MO, USA). Gene expression patterns for each gene were normalized to the median array intensity for all chips, and data from infected animals were normalized to uninfected PBS controls [13, 21] . Microarray data were analyzed with Partek GS software by a two-way ANOVA in order to look for significant differences between conditions, with sex (male/female) and treatment (PBS/myocarditis) as factors, and then, p values and fold changes were generated using Fisher's least significant difference (LSD) post hoc analysis for comparisons of sex. False discovery rate (FDR) corrections for multiple comparisons (BenjaminiHochberg) were applied to reduce the total number of false positives. Genes were considered significant if they had a p value less than 0.05. The Affymetrix gene expression data were deposited to the Gene Expression Omnibus (www.ncbi. nlm.nih.gov/geo) under accession number GSE35182.
qRT-PCR
The mouse hearts were perfused and digested with collagenase II (10,000 U/mL, Worthington, CLS-2) to release immune cells using a gentleMACs Dissociator. Immune cells were isolated using MACs magnetic microbeads for CD11b or CD45 (Miltenyi Biotec, Auburn, CA). Trizol Reagent and the PureLink Micro-to-Midi system (Invitrogen, Carlsbad, CA) were used for purification of RNA from the total hearts or immune cells. Human RNA was isolated from heart biopsies of formalinfixed, paraffin-embedded (FFPE) blocks from patients with histology-verified myocarditis. Human RNA was processed using a PureLink FFPE RNA Isolation Kit (Invitrogen, Carlsbad, CA). Quantitative RT-PCR (qRT-PCR) of gene expression was measured using Assay-on-Demand probe sets (Applied Biosystems, Foster City, CA) or RT 2 qPCR Primer Assay (Qiagen, Venlo, Netherlands) and reactions analyzed using the ABI 7000 Taqman system, as previously reported [13, 21] .
Hypoxanthine phosphoribosyltransferase (Hprt) was used for normalization.
Autoradiography [
125 I]-IodoDPA-713, used to assess TSPO levels in the heart, was synthesized using a two-step reaction process, as previously reported [29] . Desmethyl DPA-713 was first iodinated with [ 125 I]NaI in the presence of iodogen. The 125 Iradiolabeled intermediate was methylated by MeI/K 2 CO 3 / DMF and HPLC purified. The overall radioactive yield was 35-50 % with >99 % radiochemical purity. Fresh-frozen hearts were sectioned (20 μm) on a cryostat in the sagittal plane and thaw mounted onto poly-L-lysine-coated slides and stored at −20°C. Slides were dried for 30 min and prewashed with 50-mM Tris-HCl buffer (pH 7.4). To determine the total binding, slides were incubated for 1 h at RT in buffer containing 0.8-nM [ 125 I]-IodoDPA-713 (specific activity 2,200 Ci/mmol). To measure nonspecific binding, adjacent slides were incubated in the presence of 50-μM cold racemic PK11195 (Sigma, St. Louis, MO). After incubation, slides were washed and exposed to film at RT for 20 min. Images were captured and analyzed using MCID (InterFocus Imaging Ltd., Cambridge, England) calibrating for density using [
125 I]-microscales. The mean value for all sections/heart was used for statistical analyses.
Saturation Isotherms (B max and K d )
The whole hearts were homogenized in 50 volumes of TrisHCl buffer (pH 7.4) and centrifuged at 40,000×g for 30 min at 4°C. The pellet was resuspended in 50 volumes of Tris-HCl buffer (pH 7.4) and recentrifuged. The pellet was resuspended in 4.5-mL buffer and the protein concentration determined by Lowry assay (BioRad Laboratories, Hercules, CA), using bovine serum albumin as a standard. The preparation was used immediately for saturation isotherms. Fifty microliters of heart protein was incubated in a total volume of 500 μL with 100 μL of [ 3 H]-R-PK11195 at 4°C for 1 h. Nonspecific binding was measured by incubating 50-μL heart protein with 50-μM cold racemic PK11195. For [
3 H]-R-PK11195 saturation isotherms, heart protein was incubated with ligand ranging in concentration from 0.25 to 20 nM. A Brandel filtering system with Whatman GF/B filter paper (Brandel Inc, Gaithersburg, MD) was used to terminate the reaction. Filters were washed four times with 5-mL cold 50-mM Tris-HCl buffer (pH 7.4). Radioactivity trapped on the filters was measured by liquid scintillation spectrometry. The EBDA/Ligand in Kell version 6 program (Biosoft, Cambridge, UK) was used to determine the maximal number of binding sites (B max ) and the affinity constant (K d ) using a one site model.
MicroSPECT Imaging
A micro single-photon emission computed tomography (microSPECT) small animal SPECT/computed tomography (CT) system (Gamma Medica-Ideas) was used for image acquisition, as previously reported [29, 30] . Mice were anesthetized with isoflourane prior to imaging. [ 125 I]-IodoDPA-713 of 1-2 mCi was injected intravenously and images acquired immediately after injection. The SPECT projection data were acquired using two low energy, high-resolution parallel-hole collimators with a radius of rotation of 4.65 cm. The tomographic data were acquired in 512 projections to allow anatomic coregistration. Data were reconstructed using the ordered subsets expectation maximization algorithm and analyzed using AMIDE software (SourceForge). Data were analyzed using analysis software and a time-activity curve of [ 
Statistical Analysis
Normally distributed data comparing two groups were analyzed using a two-tailed Student's t test. Nonparametric data comparing two groups were analyzed using the MannWhitney rank sum test with a Bonferroni correction for multiple comparisons. Analysis of microarray data was performed with Partek Genomics Suite version 6.4 (St. Louis, MO) by a two-way ANOVA to examine significant differences between conditions (with sex and myocarditis as factors). Data are expressed as mean±standard error of the mean (SEM). p values less that 0.05 were considered statistically significant.
Results
TSPO Expression Detected in the Heart by Microarray
Although TSPO is known to be expressed in cardiac tissues, atherosclerotic plaques, and in CD11b + microglia/ macrophages [6, 9, 15, [18] [19] [20] , the relationship between TSPO and myocardial inflammation has not been previously investigated. Currently, there is a lack of noninvasive imaging modalities to directly image myocardial inflammation in patients [31] . Recently, cardiac MRI was used to image myocardial inflammation in a mouse model of autoimmune myocarditis [32] . Here, we chose to investigate TSPO because it regulates steroid expression in CD11b + immune cells, which comprise approximately 80 % of the infiltrate and predict the severity of acute myocarditis and progression to DCM and heart failure in male mice with CVB3 myocarditis [13, 21, 24, 25] .
In this study, we assessed the relative expression of TSPO in the heart using microarray analysis of undiseased, PBSinoculated male and female mice versus mice with CVB3 myocarditis (Tables 1 and 2 ). We found that TSPO was significantly increased in the heart of male mice with CVB3 myocarditis compared with PBS controls by microarray (fold change 1.9, p=0.002, Table 2 ) but not significantly changed in female mice with CVB3 myocarditis (fold change 1.4, p=0.05). Twice as many genes linked to TSPO activation in macrophages, such as steroidogenic acute regulatory protein (Star) and ATP-binding cassette (Abcg1), were elevated in the heart of male mice with CVB3 myocarditis (25 genes; Fig. 1a , Table 2 ) compared with female mice with myocarditis (12 genes; Table 1 ) according to microarray analysis. Figure 1a illustrates genes related to TSPO that are upregulated in male mice during myocarditis that are important in the function of CD11b + macrophages (these genes are associated with the formation of foam cells in atherosclerosis, for example) [33] . Increased expression of TSPO (p= 0.0001), CD11b (p=0.0001), Star (p=0.0002), and Abcg1 (p=6×10
) was confirmed in the heart of male mice during CVB3 myocarditis by qRT-PCR (Fig. 1b) .
Imaging Myocardial TSPO
PET/CT and SPECT/CT are routinely used to assess brain inflammation clinically in adults and children using TSPOspecific ligands like PK11195 and DPA-713 [6, 11, 34, 35] . These imaging modalities have been miniaturized for the use in small animals (i.e., microSPECT) and have been found to be an increasingly useful tool for translating human studies [36] . Next, we asked whether TSPO imaging could be used to detect myocardial inflammation in mice. We used in vivo [ 125 I]-IodoDPA-713 microSPECT to assess TSPO expression in the heart during acute CVB3 myocarditis in male BALB/c mice. MicroSPECT/CT imaging revealed higher TSPO radioligand uptake in the heart during CVB3 myocarditis compared with PBS-inoculated controls (Fig. 2a) , which was verified by quantitative analysis (n=3/group, p= 0.01; Fig. 2b ). TSPO uptake in the lung (red lobes around the heart; Fig. 2a) was not significantly different during CVB3 myocarditis than PBS controls (n=3/group, p=0.83; Fig. 2b ), demonstrating that TSPO uptake could be detected at higher levels in the hearts with myocarditis compared with healthy controls.
Sex Differences in Cardiac TSPO Expression
Although most inflammatory brain diseases occur more frequently and are more severe in men than in women [37] , to our knowledge, there are no published reports of sex differences in TSPO expression in brain microglia. Because TSPO is necessary for steroid synthesis within immune and cardiac cells, we investigated whether sex differences existed in TSPO expression in the heart using quantitative receptor autoradiography [6, 29] . Traditionally, TSPO is characterized in animal models using radioligand binding assays and autoradiography due to the lack of suitable TSPO-reactive antibodies for flow cytometry or ELISA and because TSPO deficiency in mice is embryonically lethal, while conditional knockouts are not yet available [6, 38] . We found that PBS-treated female mice had higher constitutive TSPO binding (proportional p=0.005, density p=0.02) and mRNA levels (p=0.02) than PBStreated male mice (Fig. 3a-d) . TSPO levels were significantly increased in male mice with acute CVB3 myocarditis compared with control male mice by qRT-PCR (Fig. 1b) and by proportional area (p=0.03) or total density (p=0.04) of (Fig. 3b, c) but not for female mice with myocarditis compared with PBS controls (p=0.3; Fig. 3b ) confirming the microarray data (Tables 1 and 2 ). The binding affinity (K d ) of [ 3 H]-R-PK11195 for TSPO did not differ significantly between controls or CVB3 myocarditis in male or female mice (PBS vs CVB3 female mice p=0.40, PBS vs CVB3 male mice p=0.39, PBS male vs female mice p=0.07, Bonferroni correction p= 0.29; CVB3 male vs female mice p= 0.33; Fig. 4b, left) . However, TSPO levels were increased in male and female mice with CVB3 myocarditis compared with controls when assessing the maximum number of [ 3 H]-R-PK11195 binding sites (B max ) (PBS vs CVB3 female mice p=0.002, Bonferroni correction p=0.009; PBS vs CVB3 male subjects p= 0.01, Bonferroni correction p= 0.04; Fig. 4b, right) .
To determine whether sex differences existed in cardiac TSPO expression in myocarditis patients, we extracted RNA from myocardial biopsy samples with histologyverified myocarditis and examined TSPO mRNA levels by qRT-PCR. We found that men with myocarditis had significantly higher expression of TSPO in the heart than women (n=10/sex, p=0.03; Fig. 3e ). Overall, these data indicate that sex differences in TSPO expression exist in the heart during CVB3 myocarditis.
TSPO Expression in Cardiac CD11b
+ Immune Cells TSPO is expressed during brain inflammation within CD11b + microglia/macrophages [6] [7] [8] . CD11b, also known as complement receptor 3, is upregulated on activated immune cells like macrophages following infection [24] . We showed previously using flow cytometry that male mice with CVB3 myocarditis have more CD11b + immune cells in the heart than female mice [24] that is due to testosterone [25] . Here, we found that CD11b mRNA expression was significantly higher in the heart of male mice with CVB3 myocarditis compared with female mice (n=10/sex, p=0.02; Fig. 3f ) and in men with histology-proven myocarditis compared with women (n=7/ Fig. 1 TSPO-related genes upregulated in the heart of mice during CVB3 myocarditis. a Cartoon of relationship of genes related to cholesterol influx/metabolism and TSPO-related steroid synthesis that occur in CD11b + immune cells like macrophages. Several of the genes found to be upregulated in the heart of male mice with CVB3 myocarditis at day 10 pi compared with PBS control male mice by microarray (see Table 2 ) are shown in blue. b Verification by qRT-PCR of several genes upregulated in the heart of male mice with CVB3 myocarditis compared with PBS-inoculated controls. Data show the mean relative gene expression (RGE)±SEM of 7-10 mice/group. PBS versus CVB3 analyzed using the Mann-Whitney rank sum test Fig. 2 MicroSPECT imaging detects myocardial inflammation in male mice with myocarditis. a Representative X-ray computed tomography (CT) and single-photon emission computed tomography (SPECT) images of the lung (red lobes) and heart (outlined) from male mice inoculated either with PBS or CVB3 to induce myocarditis. [ 125 I]-IodoDPA-713 binding to TSPO in the lung and heart of male mice at day 10 pi during acute CVB3 myocarditis versus control male mice that received PBS. Data show the mean % uptake over controls±SEM of three mice/group analyzed using paired Student's t test sex, p=0.003; Fig. 3g ). Typical CD11b + staining by immunohistochemistry is shown from a myocarditis patient (Fig. 5,  right) indicating that, similar to CVB3 myocarditis [24, 25] , most of the inflammatory cells in the heart of myocarditis patients express CD11b. To determine whether TSPO was present in CD11b + immune cells during CVB3 myocarditis in mice, we separated CD11b + cells from other immune cells using magnetic beads and examined TSPO levels by qRT- qRT-PCR in male and female mice inoculated with PBS (n=10/group). e TSPO expression in the heart of patients with histology-verified myocarditis using qRT-PCR (n=10/group). f CD11b expression in the heart of male and female mice with CVB3 myocarditis at day 10 pi (n=10/group). g CD11b expression in the heart of patients with histology-verified myocarditis using qRT-PCR (n=7/group). h TSPO mRNA expression in CD11b + versus other immune cells extracted from the heart using magnetic beads during CVB3 myocarditis in male mice at day 10 pi (n=9). b-h Data show the mean±SEM analyzed by Mann-Whitney rank sum test PCR. We found that TSPO was expressed predominantly in CD11b + inflammatory cells compared with other immune cell types during CVB3 myocarditis (n= 9/group, p= 0.04; Fig. 3h ), similar to the findings with brain inflammation. These data suggest that TSPO would be a good biomarker to assess the severity of myocarditis.
Testosterone Increases TSPO Expression in Immune Cells
To determine whether testosterone was responsible for sex differences in TSPO levels in the heart during CVB3 myocarditis, we gonadectomized (Gdx) or removed the testes from male BALB/c mice or performed a sham operation (to control for the stress of the operation which affects the inflammatory response) and inserted a control (Con) or slow-release testosterone (Te) pellet subcutaneously (which should reverse the effect of Gdx if testosterone is responsible for the effect), as previously reported [21, 25] . After recovery, all mice were infected with CVB3 to induce myocarditis and TSPO levels assessed at day 10 pi during the peak of acute myocarditis. We found that removing the testes in Gdx-Con mice significantly decreased myocarditis (Fig. 6a, b) , circulating Te levels (Fig. 6c) , and TSPO mRNA levels in the whole heart by qRT-PCR (Fig. 6d ) compared with Sham-Con mice, indicating that testosterone increases TSPO levels in the heart. Testosterone replacement in Gdx male mice (Gdx-Te) restored myocarditis (Fig. 6a, b) and circulating Te levels (Fig. 6c) confirming that testosterone was responsible for the decreased myocarditis in Gdx mice. However, testosterone replacement in Gdx male mice (Gdx-Te) did not increase TSPO mRNA levels from whole hearts (which is composed primarily of cardiac myocytes, fibroblasts, and immune cells), which remained low like the Gdx-Con group (Fig. 6d) . This finding suggests that testosterone was not increasing TSPO levels in cardiac tissues in general. Because sex differences in TSPO expression in the heart appeared to be due to greater Fig. 5 CD11b expression in the heart of a myocarditis patient. Representative H&E histology sections show inflammatory cells that stain dark purple (left) or CD11b + immune cells that stain brown using immunohistochemistry (right) from a patient with myocarditis. Scale bar=200 μm TSPO expression in immune cells in male mice (Fig. 3h) , we performed Gdx and Te replacement and isolated CD45 + immune cells using magnetic beads (CD45 is a general marker for immune cells). We found that Gdx significantly lowered TSPO levels in CD45 + immune cells in the heart that was reversed with Te replacement (Fig. 6e) . Thus, these data show that testosterone specifically increases TSPO + immune cells in the heart during CVB3 myocarditis in male mice.
Discussion and Translational Relevance
In this preclinical study, we demonstrate that TSPO ligands can be used to directly detect inflammation during myocarditis in mice. Because TSPO is present in the majority of inflammatory cells in the heart during myocarditis, it should also provide a good measure of the severity of disease. Although TSPO imaging is routinely used to assess brain inflammation [6] [7] [8] 17] and more recently to detect inflammation in atherosclerotic plaques [15, [18] [19] [20] , we are the first to report that imaging based on TSPO ligands and SPECT/CT can be used to detect myocardial inflammation during myocarditis.
Although myocarditis is diagnosed based on echocardiography, cMRI, and endomyocardial biopsy [3] , there are currently no noninvasive imaging tools that allow direct assessment of myocardial inflammation in patients. The ability to directly image myocardial inflammation noninvasively would improve diagnosis made by echocardiography and cMRI and allow earlier detection of disease. Knowing TSPO levels may additionally predict myocarditis patients that are at an increased risk to progress to DCM and heart failure. Furthermore, imaging for myocardial inflammation could be used to assess the efficacy of therapeutic strategies. Future studies should examine the effectiveness of TSPO imaging in male and female myocarditis and DCM patients compared with healthy controls.
We are the first to report that TSPO expression is able to distinguish differences in the severity of myocarditis between male subjects and female subjects in mice and in humans. Although most inflammatory brain diseases occur more frequently and are more severe in men than in women [37] , to our knowledge, no one has examined whether sex differences in TSPO expression occur in brain microglia. Whether sex differences exist in TSPO levels in atherosclerotic plaques has also not been investigated. Baseline sex differences in TSPO Fig. 6 Testosterone increases TSPO expression in inflammatory cells in the heart during CVB3 myocarditis at day 10 pi. a Representative H&E histology sections of CVB3 myocarditis in male mice that received a sham operation and control pellet (Sham-Con) were gonadectomized (Gdx) and received a control pellet (Gdx-Con) or were Gdx and received testosterone replacement (Gdx-Te). Magnification×64. b Myocarditis was assessed from histology sections as the percentage of the heart with inflammation compared with the overall size of the heart section using a microscope eyepiece grid (n=15-30 mice/group ). d Relative gene expression (RGE) of TSPO in the whole heart by qRT-PCR (n=10/ group). Student's t test p values a=0.04, b=0.02, c=0.37 (Bonferroni correction a=0.12, b=0.06, c=1.0). e CD45 + immune cells were isolated from the heart of male mice with CVB3 myocarditis using magnetic microbead isolation and RGE of TSPO assessed by qRT-PCR (n=10 mice/group). Mann-Whitney rank sum test p values a=0.06, b=0.85, c=0.01 (Bonferroni correction a=0.18, b=1.0, c=0.03) levels in the heart were found in mice, with female mice having higher constitutive expression of TSPO than male mice prior to disease. A potential explanation for sex differences in TSPO levels is that steroid hormone response elements, including those activated by the androgen or estrogen receptor, have been identified within mouse and human Tspo promoters, suggesting that sex hormones influence TSPO expression [10] . Interestingly, administration of TSPO ligands have been found to alter testosterone and estrogen levels in sera [39] , perhaps indicating a positive feedback loop [13] . Our finding that testosterone increased TSPO primarily in immune cells in the heart during CVB3 myocarditis suggests that the higher cardiac TSPO expression observed in men and male mice with myocarditis may be due to more TSPO + CD11b cells in the inflammatory infiltrate of male subjects than female subjects. Activation of monocytes in culture is known to upregulate TSPO expression that tracks with elevated CD11b, tumor necrosis factor, interleukin (IL)-1β, and IL-8 [40, 41] , suggesting a relationship between TSPO activation and immune function [13] . Interestingly, TSPO has been detected on the cell membrane of immune cells and in compartments of the cell devoid of mitochondria suggesting that TSPO has physiologic functions in immune cells besides regulating mitochondrial activity [9, 42] . We found previously that activation of the androgen receptor and TSPO in the spleen during the innate immune response to CVB3 infection are associated with inflammatory gene changes that confer susceptibility to cardiovascular disease [13] . Future studies should examine whether TSPO promotes acute inflammation that leads to more severe myocarditis and DCM in male subjects. This preclinical study suggests that TSPO ligands can be used as a noninvasive imaging technique to detect myocardial inflammation in men and women with myocarditis and inflammatory DCM. Future studies will need to determine baseline expression levels of TSPO in the hearts of healthy men and women to determine whether levels are increased enough during acute myocarditis to be diagnostically or therapeutically useful. Ethical Standard Authors declare that the experiments in this manuscript comply with the current laws of the USA.
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